MEDINDIA
English
हिन्दी
Español
français
中文
Email
17-alpha-Hydroxyprogesterone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Hydroxyprogesterone caproate.
Anhydrous Tacrolimus
The therapeutic efficacy of Miglustat can be decreased when used in combination with Tacrolimus.
Aripiprazole
The therapeutic efficacy of Miglustat can be decreased when used in combination with Aripiprazole.
Arsenic Trioxide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Arsenic trioxide.
Articaine
The therapeutic efficacy of Miglustat can be decreased when used in combination with Articaine.
Asenapine
The therapeutic efficacy of Miglustat can be decreased when used in combination with Asenapine.
Atazanavir
The therapeutic efficacy of Miglustat can be decreased when used in combination with Atazanavir.
Bendroflumethiazide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Bendroflumethiazide.
Betamethasone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Betamethasone.
Brexpiprazole
The therapeutic efficacy of Miglustat can be decreased when used in combination with Brexpiprazole.
Bumetanide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Bumetanide.
Buserelin
The therapeutic efficacy of Miglustat can be decreased when used in combination with Buserelin.
Ceritinib
The therapeutic efficacy of Miglustat can be decreased when used in combination with Ceritinib.
Chlorothiazide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Chlorothiazide.
Chlorpropamide
Miglustat may increase the hypoglycemic activities of Chlorpropamide.
Chlorthalidone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Chlorthalidone.
Clozapine
The therapeutic efficacy of Miglustat can be decreased when used in combination with Clozapine.
coenzyme Q10
The therapeutic efficacy of Miglustat can be increased when used in combination with Ubidecarenone.
Corticotropin
The therapeutic efficacy of Miglustat can be decreased when used in combination with Corticotropin.
Cortisone Acetate
The therapeutic efficacy of Miglustat can be decreased when used in combination with Cortisone acetate.
Cyclopenthiazide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Cyclopenthiazide.
Cyproterone Acetate
The therapeutic efficacy of Miglustat can be decreased when used in combination with Cyproterone acetate.
Dabrafenib
The therapeutic efficacy of Miglustat can be decreased when used in combination with Dabrafenib.
Danazol
The therapeutic efficacy of Miglustat can be decreased when used in combination with Danazol.
Darunavir
The therapeutic efficacy of Miglustat can be decreased when used in combination with Darunavir.
Desogestrel
The therapeutic efficacy of Miglustat can be decreased when used in combination with Desogestrel.
Dexamethasone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Dexamethasone.
Diazoxide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Diazoxide.
Dienogest
The therapeutic efficacy of Miglustat can be decreased when used in combination with Dienogest.
Disopyramide
Miglustat may increase the hypoglycemic activities of Disopyramide.
Drospirenone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Drospirenone.
Epinephrine
The therapeutic efficacy of Miglustat can be decreased when used in combination with Epinephrine.
Estradiol
The therapeutic efficacy of Miglustat can be decreased when used in combination with Estradiol.
Ethacrynate
The therapeutic efficacy of Miglustat can be decreased when used in combination with Etacrynic acid.
Ethacrynic Acid
The therapeutic efficacy of Miglustat can be decreased when used in combination with Etacrynic acid.
Ethinyl Estradiol
The therapeutic efficacy of Miglustat can be decreased when used in combination with Ethinyl Estradiol.
Ethynodiol Diacetate
The therapeutic efficacy of Miglustat can be decreased when used in combination with Ethynodiol diacetate.
Etonogestrel
The therapeutic efficacy of Miglustat can be decreased when used in combination with Etonogestrel.
Everolimus
The therapeutic efficacy of Miglustat can be decreased when used in combination with Everolimus.
Fludrocortisone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Fludrocortisone.
Fosamprenavir
The therapeutic efficacy of Miglustat can be decreased when used in combination with Fosamprenavir.
Furosemide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Furosemide.
Gliclazide
Miglustat may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Miglustat may increase the hypoglycemic activities of Glimepiride.
Glipizide
Miglustat may increase the hypoglycemic activities of Glipizide.
Glyburide
Miglustat may increase the hypoglycemic activities of Glyburide.
Goserelin
The therapeutic efficacy of Miglustat can be decreased when used in combination with Goserelin.
Histrelin
The therapeutic efficacy of Miglustat can be decreased when used in combination with Histrelin.
Hydrochlorothiazide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Hydrochlorothiazide.
Hydrocortisone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Hydroflumethiazide.
hydroxyprogesterone caproate (USP)
The therapeutic efficacy of Miglustat can be decreased when used in combination with Hydroxyprogesterone caproate.
Iloperidone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Iloperidone.
Indapamide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Indapamide.
Indinavir
The therapeutic efficacy of Miglustat can be decreased when used in combination with Indinavir.
INDINAVIR ANHYDROUS
The therapeutic efficacy of Miglustat can be decreased when used in combination with Indinavir.
Insulin Detemir
Miglustat may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Miglustat may increase the hypoglycemic activities of Insulin Glargine.
insulin human, rDNA origin
Miglustat may increase the hypoglycemic activities of Insulin Human.
Insulin Lispro
Miglustat may increase the hypoglycemic activities of Insulin Lispro.
Insulin, Aspart Protamine, Human
Miglustat may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Miglustat may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Miglustat may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Protamine Lispro, Human
Miglustat may increase the hypoglycemic activities of Insulin Lispro.
Lanreotide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Lanreotide.
Leuprolide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Leuprolide.
Levonorgestrel
The therapeutic efficacy of Miglustat can be decreased when used in combination with Levonorgestrel.
Lopinavir
The therapeutic efficacy of Miglustat can be decreased when used in combination with Lopinavir.
Lurasidone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Lurasidone.
Mecasermin
Miglustat may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Miglustat may increase the hypoglycemic activities of Mecasermin.
Medrogestone
The serum concentration of Miglustat can be decreased when it is combined with Medrogestone.
Medroxyprogesterone Acetate
The therapeutic efficacy of Miglustat can be decreased when used in combination with Medroxyprogesterone acetate.
Megestrol Acetate
The therapeutic efficacy of Miglustat can be decreased when used in combination with Megestrol acetate.
Mestranol
The therapeutic efficacy of Miglustat can be decreased when used in combination with Mestranol.
Methotrimeprazine
The therapeutic efficacy of Miglustat can be decreased when used in combination with Methotrimeprazine.
Methyclothiazide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Methyclothiazide.
Methylprednisolone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Methylprednisolone.
Metolazone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Metolazone.
Mifepristone
Miglustat may increase the hypoglycemic activities of Mifepristone.
Nateglinide
Miglustat may increase the hypoglycemic activities of Nateglinide.
Nelfinavir
The therapeutic efficacy of Miglustat can be decreased when used in combination with Nelfinavir.
Niacin
The therapeutic efficacy of Miglustat can be decreased when used in combination with Niacin.
Nilotinib
The therapeutic efficacy of Miglustat can be decreased when used in combination with Nilotinib.
Norethindrone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Norethisterone.
Norgestimate
The therapeutic efficacy of Miglustat can be decreased when used in combination with Norgestimate.
Octreotide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Octreotide.
Olanzapine
The therapeutic efficacy of Miglustat can be decreased when used in combination with Olanzapine.
Paliperidone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Paliperidone.
Pasireotide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Pasireotide.
Pentamidine
The therapeutic efficacy of Miglustat can be decreased when used in combination with Pentamidine.
Piperazine
The therapeutic efficacy of Miglustat can be decreased when used in combination with Piperazine.
Pipothiazine
The therapeutic efficacy of Miglustat can be decreased when used in combination with Pipotiazine.
Polythiazide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Polythiazide.
Prednisolone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Prednisolone.
Prednisone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Prednisone.
Pregabalin
The risk or severity of heart failure can be increased when Pregabalin is combined with Miglustat.
Progesterone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Progesterone.
Quetiapine
The therapeutic efficacy of Miglustat can be decreased when used in combination with Quetiapine.
Quetiapine fumarate
The therapeutic efficacy of Miglustat can be decreased when used in combination with Quetiapine.
Quinethazone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Quinethazone.
Quinine
Miglustat may increase the hypoglycemic activities of Quinine.
Regular Insulin, Human
Miglustat may increase the hypoglycemic activities of Insulin Human.
Repaglinide
Miglustat may increase the hypoglycemic activities of Repaglinide.
Risperidone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Risperidone.
Ritonavir
The therapeutic efficacy of Miglustat can be decreased when used in combination with Ritonavir.
Saquinavir
The therapeutic efficacy of Miglustat can be decreased when used in combination with Saquinavir.
Saquinavir Mesylate
The therapeutic efficacy of Miglustat can be decreased when used in combination with Saquinavir.
Sirolimus
The therapeutic efficacy of Miglustat can be decreased when used in combination with Sirolimus.
Sulfadiazine
Miglustat may increase the hypoglycemic activities of Sulfadiazine.
Sulfamethoxazole
Miglustat may increase the hypoglycemic activities of Sulfamethoxazole.
Sulfisoxazole
Miglustat may increase the hypoglycemic activities of Sulfisoxazole.
Sunitinib
Miglustat may increase the hypoglycemic activities of Sunitinib.
Tacrolimus
The therapeutic efficacy of Miglustat can be decreased when used in combination with Tacrolimus.
Temsirolimus
The therapeutic efficacy of Miglustat can be decreased when used in combination with Temsirolimus.
Thioctic Acid
Lipoic Acid may increase the hypoglycemic activities of Miglustat.
Tipranavir
The therapeutic efficacy of Miglustat can be decreased when used in combination with Tipranavir.
Tolazamide
Miglustat may increase the hypoglycemic activities of Tolazamide.
Tolbutamide
Miglustat may increase the hypoglycemic activities of Tolbutamide.
Torsemide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Torasemide.
Triamcinolone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Triamcinolone.
Trichlormethiazide
The therapeutic efficacy of Miglustat can be decreased when used in combination with Trichlormethiazide.
Triptorelin
The therapeutic efficacy of Miglustat can be decreased when used in combination with Triptorelin.
Vorinostat
The therapeutic efficacy of Miglustat can be decreased when used in combination with Vorinostat.
Ziprasidone
The therapeutic efficacy of Miglustat can be decreased when used in combination with Ziprasidone.
